tetano
Editor, Senior Moderator
Medicine (Baltimore)
. 2022 Mar 4;101(9):e27759.
doi: 10.1097/MD.0000000000027759.
Hydrogen-oxygen therapy alleviates clinical symptoms in twelve patients hospitalized with COVID-19: A retrospective study of medical records
Peng Luo[SUP] 1 [/SUP], Yuanfang Ding[SUP] 2 [/SUP], Yuan He[SUP] 3 [/SUP], Dafeng Chen[SUP] 4 [/SUP], Qing He[SUP] 3 [/SUP], Zufeng Huang[SUP] 1 2 [/SUP], Shian Huang[SUP] 1 [/SUP], Wei Lei[SUP] 1 3 4 [/SUP]
Affiliations
Abstract
A global public health crisis caused by the 2019 novel coronavirus disease (COVID-19) leads to considerable morbidity and mortality, which bring great challenge to respiratory medicine. Hydrogen-oxygen therapy contributes to treat severe respiratory diseases and improve lung functions, yet there is no information to support the clinical use of this therapy in the COVID-19 pneumonia.A retrospective study of medical records was carried out in Shishou Hospital of Traditional Chinese Medicine in Hubei, China. COVID-19 patients (aged ≥ 30 years) admitted to the hospital from January 29 to March 20, 2020 were subjected to control group (n = 12) who received routine therapy and case group (n = 12) who received additional hydrogen-oxygen therapy. The clinical characteristics of COVID-19 patients were analyzed. The physiological and biochemical indexes, including immune inflammation indicators, electrolytes, myocardial enzyme profile, and functions of liver and kidney, were examined and investigated before and after hydrogen-oxygen therapy.The results showed significant decreases in the neutrophil percentage and the concentration and abnormal proportion of C-reactive protein in COVID-19 patients received additional hydrogen-oxygen therapy.This novel therapeutic may alleviate clinical symptoms of COVID-19 patients by suppressing inflammation responses.
. 2022 Mar 4;101(9):e27759.
doi: 10.1097/MD.0000000000027759.
Hydrogen-oxygen therapy alleviates clinical symptoms in twelve patients hospitalized with COVID-19: A retrospective study of medical records
Peng Luo[SUP] 1 [/SUP], Yuanfang Ding[SUP] 2 [/SUP], Yuan He[SUP] 3 [/SUP], Dafeng Chen[SUP] 4 [/SUP], Qing He[SUP] 3 [/SUP], Zufeng Huang[SUP] 1 2 [/SUP], Shian Huang[SUP] 1 [/SUP], Wei Lei[SUP] 1 3 4 [/SUP]
Affiliations
- PMID: 35244034
- DOI: 10.1097/MD.0000000000027759
Abstract
A global public health crisis caused by the 2019 novel coronavirus disease (COVID-19) leads to considerable morbidity and mortality, which bring great challenge to respiratory medicine. Hydrogen-oxygen therapy contributes to treat severe respiratory diseases and improve lung functions, yet there is no information to support the clinical use of this therapy in the COVID-19 pneumonia.A retrospective study of medical records was carried out in Shishou Hospital of Traditional Chinese Medicine in Hubei, China. COVID-19 patients (aged ≥ 30 years) admitted to the hospital from January 29 to March 20, 2020 were subjected to control group (n = 12) who received routine therapy and case group (n = 12) who received additional hydrogen-oxygen therapy. The clinical characteristics of COVID-19 patients were analyzed. The physiological and biochemical indexes, including immune inflammation indicators, electrolytes, myocardial enzyme profile, and functions of liver and kidney, were examined and investigated before and after hydrogen-oxygen therapy.The results showed significant decreases in the neutrophil percentage and the concentration and abnormal proportion of C-reactive protein in COVID-19 patients received additional hydrogen-oxygen therapy.This novel therapeutic may alleviate clinical symptoms of COVID-19 patients by suppressing inflammation responses.